Scientists say eye-disease drug may also help fight COVID

Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.

Related Keywords

India ,Yunfeng Li ,Arjun Deb ,Gustavo Garcia Jr ,Karin Nielsen Saines ,Chandani Sen ,Brigitte Gomperts ,Sebastian Castillo Cario ,Kouki Morizono ,Priya Shah ,Ashok Kumar ,Samuel French ,Joseph Irudayam ,Arjit Jeyachandran ,Shen Li ,Arunachalam Ramaiah ,Yijie Wang ,Vaithilingaraja Arumugaswami ,Stem Cell Research ,Wayne State University ,David Geffen School Of Medicine ,National Institutes Of Health ,Tata Institute ,Research Award Program ,Drug Administration ,Tata Institute For Genetics ,Ucla Wm Keck Foundation ,Edythe Broad Center ,California Nanosystems Institute ,National Institutes ,Geffen School ,Regenerative Medicine ,Award Program ,Covid 19 ,Biological Sciences ,Medicine ,Research ,